Industries — page 4
Compass Third-Quarter Net Loss Widens to $27.2 Million
Third-quarter 2026 research and development expenses rose 72% to $22.0 million as net loss widened to $27.2 million. Cash and marketable securities were $163 million at September 30, 2026, which the company said is expected to fund operations into 2028.
Coherus Cuts Headcount 30% to Focus on Esophageal Cancer
LOQTORZI net revenue reached $14.0 million in the third quarter as the company narrowed its tagmokitug program and lowered the LOQTORZI sales needed to cover core cash burn.
Constellation Raises Full-Year Earnings Outlook Again
Adjusted operating earnings reached $5.06 a share in the third quarter, and the company lifted its 2026 range to $12.50–$12.80 a share.
Crescent Capital BDC Restores Net Income After Two Loss Quarters
Net investment income was $0.37 a share, and the board authorized a $50 million share repurchase.
Perspective Extends Cash Runway Into 2028
Cash, cash equivalents, and short-term investments were about $202 million as of September 30, 2026, and the company said the balance should fund planned clinical work into 2028.
Berkshire Operating Earnings Slip as Underwriting Falls
Third-quarter operating earnings were $12.71 billion, with insurance underwriting at $1.35 billion and net earnings of $22.11 billion.
Bakkt Sets First-Half 2027 Volume Target of $6 Billion
Third-quarter Total Transacting Volume was $147.9 million as Bakkt reiterated a $3 billion full-year 2026 TTV goal and reported net income of $14.3 million.
AN2 Therapeutics Clears Global Phase 2 Epetraborole Study
Cash, cash equivalents and investments were $80.2 million as of September 30, 2026, and the company said it expects to start polycythemia vera enrollment by year-end.
Alta Narrows 2026 EBITDA Outlook After Third-Quarter Loss
The equipment dealer posted a $12.2 million net loss, or $0.37 a share, and now sees 2026 Adjusted EBITDA of $165.0 million to $170.0 million.
ADC Therapeutics Completes $86.6 Million PIPE After Third-Quarter Loss
Net product revenue was $21.0 million and cash stood at $189.2 million as of September 30, 2026, with an expected runway into 2029.
Abeona Narrows Loss as ZEVASKYN Treatments Rise
Net ZEVASKYN revenue was $13.5 million in the third quarter, and the company completed six treatments as its qualified-center network reached eight sites.
HealthSpan Partners to Buy Surgery Partners in $6.0 Billion Cash Deal
The Bon Secours Mercy Health affiliate raised its offer to $25.00 a share after an unsolicited $28.00 bid, adding ticking fees if stockholder approval is obtained before March 1, 2027 and closing slips past that date.
CorMedix to Buy Heron Assets in Cash-and-Stock Deal
The biopharmaceutical company will add four hospital-focused products, including ZYNRELEF, and expects the deal to be immediately accretive.
Charles River to Buy Frontage Bioanalysis in $470 Million Cash Deal
The contract research lab is taking Frontage private with Tigermed and Dr. Song Li, then carving out Exton clinical bioanalysis and DMPK sites to lift its clinical share of a market it said is due to reach $8 billion to $9 billion by 2031.
CNH to Sell 70% of Construction Unit to Kobelco
The equipment maker will take $700 million in cash and keep a 30% stake as it advances a shift to a pure-play agriculture company.
Abeona to Buy APT-1011 in $20 Million Equity Deal
The commercial-stage biopharmaceutical company is pairing the asset-purchase of a Phase 3-ready eosinophilic esophagitis candidate with a $30 million private placement to fund the pipeline.
WhiteFiber Completes $60 Million Purchase of Two Yadkin County Industrial Properties for Data Center Development
The AI-infrastructure company closed a cash asset purchase of two industrial sites it plans to retrofit into NC-2 and NC-3 campuses near its Madison, North Carolina, flagship.
Willdan Completes $285 Million Cash Purchase of Mantis Innovation
Willdan said the combination lets clients cut consumption, buy energy more effectively, and use existing grid capacity as electricity demand rises.
Vistra Completes $4.0 Billion Cogentrix Energy Acquisition
The power generator now owns about 5,500 MW of natural gas plants across PJM, ISO New England and ERCOT, with mid-single-digit 2027 Ongoing Operations AFCFbG per-share accretion.
Victory Capital to Close First Eagle Deal by Q1 2027
The asset manager said integration planning is under way as it works toward a close subject to regulatory approvals and client consents.
Empower Brands Proposes $1.6 Billion Cash Takeover of Helen of Troy
The consumer-products consortium said the all-cash bid would create a $2.9 billion-revenue platform, a framing Helen of Troy’s board rejected as undervaluing the company.
Mapfre Affiliate to Buy Safety in $1.54 Billion Cash Deal
Stockholders approved the merger at a November special meeting; closing still awaits remaining regulatory clearances.
BRC Group to Buy Sangoma in $203.7 Million Mixed Deal
The company said the business communications solutions provider will add recurring revenue and create opportunities for operating synergies in its Communications platform.
Planet Fitness Completes Be-Fit Acquisition for €102.5 Million
The Judgement Free Zone franchisor closed the Portugal deal as a sixth international market and a second European country.
Penguin Solutions to Sell Cree LED to Transom Capital
The all-cash sale is meant to sharpen Penguin’s focus on data center AI infrastructure and memory and would advance its ongoing transformation toward a pure-play, data center-focused company.
Mueller Water Products Agrees to Transition Metering Business to ZENNER USA
The water-products maker said the agreement to transition the metering business will let it concentrate capital on stronger competitive positions.
LightPath Completes $4.5 Million Sale of China Unit
The optics maker closed a previously announced sale of its China subsidiary that leaves it with no facilities or operations in China.
Evommune to License EVO570 Outside Greater China for $30 Million Upfront
The clinical-stage biotech is adding an oral VAV1 degrader to expand into T- and B-cell-driven autoimmune diseases.
Intersnack to Buy Utz Class A Stock for $14.25 a Share in Cash, at About $2.9 Billion Enterprise Value
The German snack maker will take Utz private at $14.25 a share, with the Rice and Lissette family keeping a 50% stake.
NorthWestern Energy Group to Combine With Black Hills
The two utilities framed the merger as a scale-and-investment play aimed at data-center-driven power demand.
Kontoor Completes Sale of Lee to Authentic Brands Group
Kontoor Brands will use the sale to concentrate on Wrangler and Helly Hansen and fund a $400 million accelerated share repurchase.
Liberty Media Acquires Malone High-Vote Series B Stock
The all-stock swap is meant to keep the founder’s voting power from passing to a third party.
Five9 to Buy Level AI in $325 Million All-Cash Deal
The cloud contact-center platform said Level AI’s native CX applications will automate more voice and digital interactions and turn conversations into organization-wide insights.
First Capital to Buy First Bancorp of Indiana in $33.2 Million Stock Deal
The all-stock merger is meant to deepen First Capital's community-banking franchise across Southern Indiana and Western Kentucky.
Enhanced to Take 77% Stake in DEAG
The sports-IP company said the all-stock purchase of a controlling interest in the German live-events promoter would combine owned sports IP, a telehealth platform and about 6,000 annual events with proprietary ticketing.
Dropbox to Buy Tigris Data in AI Infrastructure Push
The cloud-storage company said the deal extends two decades of large-scale storage work into AI infrastructure, alongside new AI capabilities for existing Dropbox content.
Colony Completes First Reliance Merger Effective Nov. 1
The $163 million stock-and-cash combination created a Southeast community banking franchise with about $5 billion in assets.
Vistra Raises 2026 EBITDA Range After Record Summer
Ongoing Operations Adjusted EBITDA reached $2,378 million in the third quarter, and the company lifted 2026 guidance to $7.1 billion to $7.5 billion.
Ubiquiti Reverses Margin Dip as Revenue Hits a Record
The networking maker posted $1,026.2 million of first-quarter fiscal 2027 revenue and a 47.3% GAAP gross margin.
TechTarget Cuts 2026 Adjusted EBITDA Outlook
Third-quarter revenue was $119.2 million, 2.5% below a year earlier, as the company now sees full-year sales modestly lower and Adjusted EBITDA of $80 million to $85 million.
Treace Turns Adjusted Ebitda Positive After Expense Cuts
Adjusted EBITDA reached $0.3 million in the third quarter as Treace cut operating expenses 10% and narrowed its net loss to $12.6 million.
Tredegar Posts Loss as Extrusions Profit Collapses
Consolidated EBITDA from ongoing operations fell to $4.1 million in the third quarter as Aluminum Extrusions EBITDA dropped to $2.5 million.
Scripps Turns to Profit as Political Ads Lift Local Media
Income attributable to shareholders was $20.7 million, or 21 cents a share, after $18.8 million of restructuring costs cut 14 cents a share.
Ring Energy Swings to a Loss as Derivatives Reverse
Adjusted EBITDA rose to $57.1 million as the company spent $64.0 million on drilling and infrastructure.
Minerva's Warrant Gain Flips Third-Quarter Result to Profit
The clinical-stage biopharmaceutical company recorded $1.94 a share of GAAP net income as a $109.6 million non-cash warrant fair-value gain reversed a year-earlier loss, while the C19 Phase 3 trial of roluperidone stayed on track for 2H 2027 efficacy data.
Moderna Raises 2026 Revenue Growth Outlook After Profit Turn
Third-quarter revenue reached $1.3 billion, up 29%, and the company now expects 15% to 25% full-year growth after posting $162 million of net income.
InTest Posts Record Orders as Semiconductor Demand Rebounds
Third-quarter revenue was $35.1 million, up 33.7% from a year earlier, with net earnings of $0.15 a share after a year-ago loss.
Humana Lifts 2026 Adjusted EPS Floor After a Third-Quarter Loss
The insurer posted an adjusted loss of $0.70 a share in the third quarter and raised full-year adjusted EPS guidance to at least $9.50 from at least $9.00.
Gogo Reiterates 2026 Outlook After Galileo Shipments Rise
Third-quarter revenue was $213.2 million and the company kept full-year revenue guidance at $870 million to $895 million.
Fluor Awards Record $10.9 Billion, Lifts Backlog
Third-quarter revenue was $3.7 billion as the company booked LNG Canada Phase 2 and two Chilean copper mines and affirmed 2026 adjusted EBITDA of $500 million to $525 million.